At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Epidermal Growth Factordrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effectiveness of Epidermal Growth Factor Serum for the Improvement of Facial Skin Hydration, Elasticity, Pigmentation, and Wrinkles at the Institute of Dermatology: a Single-centered Pilot Study With a One-group Before-and-after Design
In Brief
A clinical study evaluating Epidermal Growth Factor for Aging. Completed, enrolled 28 participants across 1 site.
Detailed Summary
EGF is a polypeptide that promotes cell differentiation and collagen production while decreasing melanin production. This study is designed to study its effectiveness in improving the texture and appearance of facial skin after daily topical application. We hypothesized that EGF would improve facial skin hydration, elasticity, pigmentation, and wrinkles.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJan 2023
First PostedFeb 2023
Primary CompletionJun 2024
Study CompletionDec 2024
TodayJul 2026
First PostedFeb 13, 2023
Enrollment StartJan 30, 2023
Primary CompletionJun 5, 2024
Study CompletionDec 12, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.4 years ago
Interventions
Epidermal Growth Factordrug
Apply facial twice daily.